|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4866132A
(en)
|
1986-04-17 |
1989-09-12 |
The Research Foundation Of State University Of New York |
Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5811310A
(en)
|
1986-09-30 |
1998-09-22 |
Albert Einstein College Of Medicine Of Yeshiva Univ. |
The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
|
|
ATE243754T1
(de)
|
1987-05-21 |
2003-07-15 |
Micromet Ag |
Multifunktionelle proteine mit vorbestimmter zielsetzung
|
|
US5256334A
(en)
|
1988-09-08 |
1993-10-26 |
The Research Foundation Of The State University Of New York |
Homogeneous radiopaque polymer-organobismuth composites
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
WO1993003369A1
(en)
|
1991-08-01 |
1993-02-18 |
Voorheis Paul H |
Diagnostic method for alzheimer's disease
|
|
US5733734A
(en)
|
1991-08-14 |
1998-03-31 |
The Trustees Of The University Of Pennsylvania |
Method of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filaments
|
|
JP3534749B2
(ja)
|
1991-08-20 |
2004-06-07 |
アメリカ合衆国 |
アデノウイルスが介在する胃腸管への遺伝子の輸送
|
|
AU665025B2
(en)
|
1991-09-23 |
1995-12-14 |
Cambridge Antibody Technology Limited |
Production of chimeric antibodies - a combinatorial approach
|
|
DK0610330T3
(da)
|
1991-10-25 |
1998-01-26 |
Innogenetics Nv |
Monoklonale antistoffer mod microtubulus-associeret protein tau
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
DE69232137T2
(de)
|
1991-11-25 |
2002-05-29 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
JP2579202Y2
(ja)
|
1992-04-10 |
1998-08-20 |
株式会社小松製作所 |
圧力補償弁を備えた操作弁
|
|
US5600392A
(en)
|
1992-11-25 |
1997-02-04 |
Copal Company Limited |
Position sensor
|
|
AU680459B2
(en)
|
1992-12-03 |
1997-07-31 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
US6010913A
(en)
|
1992-12-14 |
2000-01-04 |
N.V. Innogenetics S.A. |
Isolated human tau peptide
|
|
DE69318420T2
(de)
|
1992-12-14 |
1999-01-28 |
Naamloze Vennootschap Innogenetics S.A., Gent |
Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung
|
|
US5346981A
(en)
|
1993-01-13 |
1994-09-13 |
Miles Inc. |
Radiopaque polyurethanes
|
|
DE614989T1
(de)
|
1993-02-17 |
1995-09-28 |
Morphosys Proteinoptimierung |
Verfahren für in vivo Selektion von Ligandenbindende Proteine.
|
|
ES2249761T3
(es)
|
1993-06-24 |
2006-04-01 |
Advec Inc. |
Vectores de adenovirus para terapia genica.
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
DK0737208T3
(da)
|
1993-12-21 |
2006-11-27 |
Innogenetics Nv |
Monoklonale antistoffer, der er specifikke for PHF-tau, hybridomaer, der secernerer dem, og antigen-genkendelse for disse antistoffer og deres anvendelsesmuligheder
|
|
EP0772634B1
(en)
|
1994-07-29 |
2003-03-12 |
Innogenetics N.V. |
Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications
|
|
US5625048A
(en)
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
KR20060099543A
(ko)
|
1994-12-09 |
2006-09-19 |
임페리얼 컬리지 이노베이션스 리미티드 |
유전자의 동정
|
|
AU4188196A
(en)
|
1994-12-22 |
1996-07-10 |
Nissan Chemical Industries Ltd. |
Organobismuth derivatives and process for producing the same
|
|
US5958713A
(en)
|
1995-01-31 |
1999-09-28 |
Novo Nordisk A/S |
Method of detecting biologically active substances by using green fluorescent protein
|
|
US5670477A
(en)
|
1995-04-20 |
1997-09-23 |
Joseph F. Poduslo |
Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents
|
|
US5968738A
(en)
|
1995-12-06 |
1999-10-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Two-reporter FACS analysis of mammalian cells using green fluorescent proteins
|
|
US6020192A
(en)
|
1996-01-18 |
2000-02-01 |
University Of Florida |
Humanized green fluorescent protein genes and methods
|
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
|
ES2166097T5
(es)
|
1996-08-27 |
2007-03-16 |
Novartis Vaccines And Diagnostics, Inc. |
Glicoconjugados de neisseria meningitidis de serogrupo b y procedimientos para usarlos.
|
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
|
TW371617B
(en)
|
1996-10-09 |
1999-10-11 |
Of Animal And Plant Health Inspection And Quarantine Council Of Agriculture Executive Yuan Bureau |
Method to transplant GFP into autographa californica multiple nuclear polyhedrosis virus for inflicting pest in an attempt to detect and flow up it existence and to improve life span against UV
|
|
WO1998022120A1
(en)
|
1996-11-19 |
1998-05-28 |
The Wistar Institute Of Anatomy & Biology |
Diagnostic and therapeutic reagents for alzheimer's disease
|
|
US6080849A
(en)
|
1997-09-10 |
2000-06-27 |
Vion Pharmaceuticals, Inc. |
Genetically modified tumor-targeted bacteria with reduced virulence
|
|
AR014621A1
(es)
|
1997-12-12 |
2001-03-28 |
Macromed Inc |
Un poli (etilenglicol) con forma de estrella, heterofuncional, biocompatible, metodo para su obtencion y metodo para conjugarlo con una proteina
|
|
US20040014142A1
(en)
|
1998-07-03 |
2004-01-22 |
Innogenetics N.V. |
Differential diagnosis of neurodegeneration
|
|
US5985577A
(en)
|
1998-10-14 |
1999-11-16 |
The Trustees Of Columbia University In The City Of New York |
Protein conjugates containing multimers of green fluorescent protein
|
|
AU6234700A
(en)
|
1999-07-27 |
2001-02-13 |
Abgenix, Inc. |
Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
|
|
DE60123752T2
(de)
|
2000-01-24 |
2007-08-23 |
Innogenetics N.V. |
Diagnose von tauopathien durch bestimmung des verhältnisses von tau/phospho-tau
|
|
DE60141752D1
(de)
|
2000-06-30 |
2010-05-20 |
Innogenetics Nv |
Differentielle diagnose von neurologischen krankheiten
|
|
CA2415919A1
(en)
|
2000-07-11 |
2002-01-17 |
Molecular Geriatrics Corporation |
Reagents and methods for identification of binding agents
|
|
WO2002045743A2
(en)
*
|
2000-12-09 |
2002-06-13 |
Cambridge University Technical Services Limited |
Hcv vaccines
|
|
US7466180B2
(en)
|
2000-12-12 |
2008-12-16 |
Intel Corporation |
Clock network
|
|
GB0101049D0
(en)
|
2001-01-15 |
2001-02-28 |
Univ Aberdeen |
Materials and methods relating to protein aggregation in neurodegenerative disease
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
GB0105924D0
(en)
|
2001-03-09 |
2001-04-25 |
Microscience Ltd |
Promoter
|
|
US6821504B2
(en)
|
2001-05-23 |
2004-11-23 |
New York University |
Detection of alzheimer's amyloid by magnetic resonance imaging
|
|
GB0117326D0
(en)
|
2001-07-16 |
2001-09-05 |
Univ Aberdeen |
Napthoquinone-type inhibitors of protein aggregation
|
|
AU2002355477B2
(en)
|
2001-08-03 |
2008-09-25 |
Medical Research Council |
Method of identifying a consensus sequence for intracellular antibodies
|
|
KR100754596B1
(ko)
|
2001-09-21 |
2007-09-05 |
미쯔비시 웰 파마 가부시키가이샤 |
3-치환-4-피리미돈 유도체
|
|
AU2003253014A1
(en)
|
2002-06-21 |
2004-01-06 |
Innogenetics N.V. |
Method for the diagnosis and differential diagnosis of neurological diseases
|
|
CN100572392C
(zh)
|
2002-07-12 |
2009-12-23 |
阿克松神经科学研究和发展股份有限公司 |
截短tau蛋白
|
|
US7250551B2
(en)
|
2002-07-24 |
2007-07-31 |
President And Fellows Of Harvard College |
Transgenic mice expressing inducible human p25
|
|
ES2352668T3
(es)
|
2002-08-14 |
2011-02-22 |
Mitsubishi Chemical Medience Corporation |
Anticuerpo específico para una proteína tau del sistema nervioso central.
|
|
EP1480041A1
(en)
|
2003-05-22 |
2004-11-24 |
Innogenetics N.V. |
Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
|
|
PL2784084T5
(pl)
|
2003-07-08 |
2024-12-02 |
Novartis Pharma Ag |
Przeciwciała antagonistyczne heterologicznych polipeptydów il-17a/f
|
|
US20050261475A1
(en)
|
2004-02-13 |
2005-11-24 |
Harvard Medical School |
Solid-phase capture-release-tag methods for phosphoproteomic analyses
|
|
US7238788B2
(en)
|
2004-02-18 |
2007-07-03 |
University Of Iowa Foundation |
Antibodies to phosphorylated tau, methods of making and methods of use
|
|
WO2005080594A2
(en)
|
2004-02-24 |
2005-09-01 |
Innogenetics N.V. |
Method for determining the risk of developing a neurological disease
|
|
CA2578680C
(en)
|
2004-04-15 |
2011-06-14 |
University Of Florida Research Foundation, Inc. |
Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
|
|
JP2008501781A
(ja)
*
|
2004-06-09 |
2008-01-24 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
細胞の選択的アポトーシスのための抗体
|
|
KR101699142B1
(ko)
|
2004-06-18 |
2017-01-23 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
|
CN1721437A
(zh)
*
|
2004-07-13 |
2006-01-18 |
中南大学 |
一种与Tau蛋白相关的多肽抗原及抗体
|
|
JP4730584B2
(ja)
|
2004-12-06 |
2011-07-20 |
東亞合成株式会社 |
抗菌ペプチド及びその利用
|
|
US20090016959A1
(en)
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
|
US8741260B2
(en)
|
2005-10-07 |
2014-06-03 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of GDNF to the CNS
|
|
EP1772732A1
(en)
|
2005-10-07 |
2007-04-11 |
Innogenetics N.V. |
Polymer replicated interdigitated electrode arrays for (bio)sensing applications
|
|
WO2007068105A1
(en)
|
2005-12-12 |
2007-06-21 |
Robarts Research Institute |
Method of diagnosing amyotrophic lateral sclerosis
|
|
US20070218491A1
(en)
|
2006-02-08 |
2007-09-20 |
Oligomerix, Inc. |
Oligomerization of amyloid proteins
|
|
US20110143380A1
(en)
|
2006-03-14 |
2011-06-16 |
The Washington University |
Alzheimer's disease biomarkers and methods of use
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
US8729225B2
(en)
|
2006-11-13 |
2014-05-20 |
Intrexon Corporation |
Glycogen synthase kinase heteropolyligand polypeptide
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
WO2008140639A2
(en)
|
2007-02-08 |
2008-11-20 |
Oligomerix, Inc. |
Biomarkers and assays for alzheimer's disease
|
|
US8178317B2
(en)
|
2007-05-01 |
2012-05-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identifying transforming and tumor suppressor genes
|
|
PE20090329A1
(es)
|
2007-05-30 |
2009-03-27 |
Abbott Lab |
Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
|
|
JP2010537200A
(ja)
|
2007-08-21 |
2010-12-02 |
ワシントン ユニバーシティー |
改善されたアルツハイマー診断法
|
|
US9370531B2
(en)
|
2007-08-31 |
2016-06-21 |
New York University |
Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
|
|
JP2010538611A
(ja)
|
2007-09-07 |
2010-12-16 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
タウタンパク質スクリーニングアッセイ
|
|
US8506933B2
(en)
|
2007-11-30 |
2013-08-13 |
Msdx, Inc. |
Methods of detecting a neurological condition via analysis of circulating phagocytes
|
|
WO2010009277A2
(en)
|
2008-07-15 |
2010-01-21 |
Novartis Ag |
Immunogenic amphipathic peptide compositions
|
|
US9464122B2
(en)
|
2008-08-20 |
2016-10-11 |
Oligomerix, Inc. |
Methods and compositions comprising tau oligomers
|
|
US20110312059A1
(en)
|
2008-08-20 |
2011-12-22 |
Oligomerix Inc. |
Tau protease compositions and methods
|
|
BRPI0923283A2
(pt)
|
2008-12-05 |
2017-06-06 |
Angiochem Inc |
conjugados terapêuticos de peptídeo e usos dos mesmos
|
|
US9605054B2
(en)
|
2009-02-23 |
2017-03-28 |
The Board Of Trustees Of The University Of Illinois |
Composition and method for treating a tauopathy
|
|
UA107571C2
(xx)
|
2009-04-03 |
2015-01-26 |
|
Фармацевтична композиція
|
|
US8409584B2
(en)
|
2009-05-05 |
2013-04-02 |
New York University |
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
|
|
WO2010132453A2
(en)
|
2009-05-11 |
2010-11-18 |
Nexus Dx, Inc. |
Methods and compositions for analyte detection
|
|
US8609097B2
(en)
|
2009-06-10 |
2013-12-17 |
Hoffmann-La Roche Inc. |
Use of an anti-Tau pS422 antibody for the treatment of brain diseases
|
|
CA3239368A1
(en)
|
2009-06-10 |
2010-12-16 |
New York University |
Immunological targeting of pathological tau proteins
|
|
NZ598356A
(en)
|
2009-07-30 |
2014-06-27 |
Pfizer Vaccines Llc |
Antigenic tau peptides and uses thereof
|
|
EP2470211B1
(en)
|
2009-08-28 |
2016-01-27 |
The Board of Regents of The University of Texas System |
Antibodies that bind tau oligomers
|
|
DK2496594T3
(en)
|
2009-11-06 |
2018-03-05 |
The J David Gladstone Inst |
METHODS AND COMPOSITIONS FOR MODULATING TAU LEVELS
|
|
EP3527220A1
(en)
|
2010-08-12 |
2019-08-21 |
AC Immune S.A. |
Vaccine engineering
|
|
ES2548686T3
(es)
|
2010-10-07 |
2015-10-20 |
Ac Immune S.A. |
Anticuerpos que reconocen fosfo-Tau
|
|
BR112013008765B8
(pt)
*
|
2010-10-11 |
2023-05-02 |
Biogen Idec Int Neuroscience Gmbh |
Anticorpos monoclonais anti-tau humano isolados ou um fragmento de ligação à tau dos mesmos, métodos de preparação dos mesmos, polinucleotídeo ou polinucleotídeos, vetor ou vetores, composição, método in vitro de diagnóstico ou monitoramento da progressão de uma tauopatia neurodegenerativa em um indivíduo humano, método in vitro para diagnosticar uma tauopatia neurodegenerativa em um indivíduo humano, e kit útil para o diagnóstico de uma tauopatia neurodegenerativa
|
|
US8703137B2
(en)
|
2011-01-31 |
2014-04-22 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
EP2686418A4
(en)
|
2011-03-17 |
2015-04-22 |
Minerva Biotechnologies Corp |
METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS
|
|
GB201111361D0
(en)
|
2011-07-04 |
2011-08-17 |
Nordic Bioscience As |
Biochemical markers for neurodegenerative conditions
|
|
GB201112056D0
(en)
*
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
ES2656442T3
(es)
|
2011-09-19 |
2018-02-27 |
Axon Neuroscience Se |
Terapia basada en proteínas y diagnóstico de una patología mediada por tau en la enfermedad de Alzheimer
|
|
KR102129220B1
(ko)
|
2011-09-23 |
2020-07-02 |
에이씨 이뮨 에스.에이. |
백신 요법
|
|
RU2639537C2
(ru)
|
2011-10-07 |
2017-12-21 |
Ац Иммуне С.А. |
Фосфоспецифичные антитела, распознающие тау
|
|
CA2853100A1
(en)
|
2011-10-24 |
2013-05-02 |
Intellect Neurosciences, Inc. |
Compositions and methods for treatment of proteinopathies
|
|
US9371376B2
(en)
|
2011-12-20 |
2016-06-21 |
Janssen Biotech, Inc. |
Anti-PHF-tau antibodies and their uses
|
|
JP6293731B2
(ja)
|
2012-04-05 |
2018-03-14 |
エーシー イミューン エス．エー． |
ヒト化タウ抗体
|
|
HK1209768A1
(en)
*
|
2012-07-03 |
2016-04-08 |
Washington University |
Antibodies to tau
|
|
PE20150646A1
(es)
|
2012-08-16 |
2015-05-21 |
Ipierian Inc |
Metodos de tratamiento de una tauopatia
|
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
ES2800827T3
(es)
*
|
2013-06-10 |
2021-01-04 |
Ipierian Inc |
Procedimientos de tratamiento de una tauopatía
|
|
US20160122421A1
(en)
|
2013-06-10 |
2016-05-05 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
EP3074420A2
(en)
|
2013-11-27 |
2016-10-05 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
WO2015122922A1
(en)
|
2014-02-14 |
2015-08-20 |
Ipierian, Inc. |
Tau peptides, anti-tau antibodies, and methods of use thereof
|